2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Stage II Urethral Cancer AJCC v8: new trials by email Literature Review of Stage II Urethral Cancer AJCC v8 trials Research Report on Stage II Urethral Cancer AJCC v8
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer Avelumab, Cisplatin, Fluorouracil - Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall, Stage II Bladder Cancer AJCC v8 | Phase 2 | Completed | Mayo Clinic | 2 | 2018-09-19 | 2023-01-06 |
| Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer Erlotinib Hydrochloride - Recurrent Bladder Urothelial Carcinoma, Recurrent Renal Pelvis Urothelial Carcinoma | Phase 2 | Completed | M.D. Anderson Cancer Center | 34 | 2008-06-10 | 2020-09-10 |
Ureteral Neoplasms (2) · Urethral Neoplasms (2) · Urinary Bladder Neoplasms (2)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Ureteral Diseases (2) · Urethral Diseases (2) · Urinary Bladder Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Urologic Diseases (2) · Urologic Neoplasms (2)
1,2-diaminocyclohexaneplatinum II citrate (1) · Cisplatin (1) · Erlotinib Hydrochloride (1) · Fluorouracil (1) · Mitomycin (1) · Mitozytrex (1) · Platinum (1) · Radiation (1) · Radiotherapy (1) · avelumab (1) · dehydroftorafur (1)
M.D. Anderson Cancer Center (1) · Mayo Clinic (1)
United States (2)
Arlene Siefker-Radtke (1) · Parminder Singh (1)
P30CA016672 (1)